Novo weight loss drug trial shows improvement in fatty liver disease
Novo Nordisk said Friday that its weight-loss drug achieved the primary goal of a late-stage study in patients with fatty liver disease, reducing scarring of the organ without worsening the condition.
ПОПУЛЯРНЫЕ ПОСТЫ
Spain’s vice-president Ribera blames floods on climate change
Ноябрь 22, 2024
Storm lashes northwestern US, killing two people
Ноябрь 22, 2024
Iceland volcano erupts for tenth time in three years
Ноябрь 22, 2024
A banana wrapped in duct tape sells for $6.2 million at auction
Ноябрь 22, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ